Zynerba Pharmaceuticals Inc. (ZYNE) tumbled -6.4% or -0.76 to $11.11. It is about 272770 shares traded, which is 82.0% compare to the average total volume 332630. The market cap of ZYNE is $150.58 million. The year to date change is -8.66%. The 52 week price range is from $5.42 to $25.95. Price of ZYNE have changed -1.66% during last week. It have changed -8.66% over last month, 21.62% over last 3 months, -15.82% over last 6 months and -30.22% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 12.41. It is 11.70% above current price. The 200-day Moving Averages for ZYNE is 13.42. It is 20.79% above current price. The 52-week High is 25.95. It is 133.57% from the current price. The 52-week Low is 5.42. It is -51.22% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 7.64 on 2018-01-12. Short % to float is 19.50%. There are some statistics of ZYNE. It is has market cap $150.58 million. The share outstanding is 13.55 million. The average volume is 332630. The percent of top 15 Institution holding is 30.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -64.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -56.31%.